Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:249-255
doi: 10.1161/CIRCULATIONAHA.106.614420
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ong, A. T.L.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ong, A. T.L.
Right arrow Articles by Serruys, P. W.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Bypass Surgery
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease
Right arrow Chronic ischemic heart disease

(Circulation. 2006;114:249-255.)
© 2006 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Complete Revascularization

Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention

Andrew T.L. Ong, MBBS, FRACP; Patrick W. Serruys, MD, PhD

From the Department of Interventional Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, the Netherlands.

Correspondence to Professor P.W. Serruys, MD, PhD, Thoraxcentre, Ba 583, Dr Molewaterplein 40, 3015-GD Rotterdam, The Netherlands. E-mail p.w.j.c.serruys@erasmusmc.nl


Key Words: angioplasty • bypass • occlusion • revascularization • surgery • stents


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
The concept of complete revascularization arose from the early studies on coronary artery bypass grafting (CABG) surgery whereby some publications demonstrated that patients who were completely revascularized enjoyed a mortality benefit over those who were incompletely revascularized, thus setting the standard for the field of CABG.1–3 Over the past 3 decades, CABG has evolved from saphenous vein grafting to more frequent use of arterial grafting, better perioperative management, development of a less invasive approach, and off-pump surgery as a genuine option. The development of percutaneous coronary interventions (PCIs) for the treatment of coronary stenosis has developed out of the treatment of single-vessel disease to become an alternative to CABG in the treatment of multivessel disease.4,5 PCI has progressed from balloon angioplasty to coronary stents,6,7 and now drug-eluting stents,8 with the simultaneous development of new devices to treat chronic total occlusions (CTOs). For both groups of patients treated by either CAGB or PCI, there is recognition that aggressive pharmacological secondary-prevention therapies such as statins and antiplatelet agents are beneficial and are now commonly used.

Despite the mantra of complete revascularization, none of the current guidelines set out by the American or European cardiology societies formally discuss the issue in detail. Although this topic has been addressed separately within each revascularization strategy, to date there has been only 1 report from a randomized trial that compared the end point of complete revascularization between CABG and PCI.9 This review will therefore address the issue separately for CABG and for PCI and finally provide . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
E. L. Hannan, C. Wu, G. Walford, D. R. Holmes, R. H. Jones, S. Sharma, and S. B. King III
Incomplete Revascularization in the Era of Drug-Eluting Stents: Impact on Adverse Outcomes
J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Holzhey, S. Jacobs, M. Mochalski, D. Merk, T. Walther, F. W. Mohr, and V. Falk
Minimally Invasive Hybrid Coronary Artery Revascularization
Ann. Thorac. Surg., December 1, 2008; 86(6): 1856 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Martuscelli, F. Clementi, M. M. Gallagher, A. D'Eliseo, G. Chiricolo, A. Nigri, B. Marino, F. Romeo, and on behalf of CABRI trialists
Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial
Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 4 - 8.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. G. Camici, S. K. Prasad, and O. E. Rimoldi
Stunning, Hibernation, and Assessment of Myocardial Viability
Circulation, January 1, 2008; 117(1): 103 - 114.
[Full Text] [PDF]